Lechtenberg BC - Search Results

1

Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability.

Olson EJ, Lechtenberg BC, Zhao C, Rubio de la Torre E, Lamberto I, Riedl SJ, Dawson PE, Pasquale EB. Olson EJ, et al. Among authors: lechtenberg bc. ACS Med Chem Lett. 2016 Jun 25;7(9):841-6. doi: 10.1021/acsmedchemlett.6b00132. eCollection 2016 Sep 8. ACS Med Chem Lett. 2016. PMID: 27660688 Free PMC article.

2

Structural mechanisms in NLR inflammasome signaling.

Lechtenberg BC, Mace PD, Riedl SJ. Lechtenberg BC, et al. Curr Opin Struct Biol. 2014 Dec;29:17-25. doi: 10.1016/j.sbi.2014.08.011. Epub 2014 Sep 15. Curr Opin Struct Biol. 2014. PMID: 25201319 Free PMC article. Review.

3

Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor.

Lamberto I, Lechtenberg BC, Olson EJ, Mace PD, Dawson PE, Riedl SJ, Pasquale EB. Lamberto I, et al. Among authors: lechtenberg bc. ACS Chem Biol. 2014 Dec 19;9(12):2787-95. doi: 10.1021/cb500677x. Epub 2014 Oct 14. ACS Chem Biol. 2014. PMID: 25268696 Free PMC article.

4

The elastase-PK101 structure: mechanism of an ultrasensitive activity-based probe revealed.

Lechtenberg BC, Kasperkiewicz P, Robinson H, Drag M, Riedl SJ. Lechtenberg BC, et al. ACS Chem Biol. 2015 Apr 17;10(4):945-51. doi: 10.1021/cb500909n. Epub 2015 Jan 22. ACS Chem Biol. 2015. PMID: 25581168

5

Rosetta Stone of NLR Innate Immunity.

Lechtenberg BC, Riedl SJ. Lechtenberg BC, et al. Trends Biochem Sci. 2016 Jan;41(1):6-8. doi: 10.1016/j.tibs.2015.11.008. Epub 2015 Nov 26. Trends Biochem Sci. 2016. PMID: 26631419 Free PMC article.

6

Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.

Lechtenberg BC, Rajput A, Sanishvili R, Dobaczewska MK, Ware CF, Mace PD, Riedl SJ. Lechtenberg BC, et al. Nature. 2016 Jan 28;529(7587):546-50. doi: 10.1038/nature16511. Epub 2016 Jan 20. Nature. 2016. PMID: 26789245 Free PMC article.

7

Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors.

Lechtenberg BC, Mace PD, Sessions EH, Williamson R, Stalder R, Wallez Y, Roth GP, Riedl SJ, Pasquale EB. Lechtenberg BC, et al. ACS Med Chem Lett. 2017 Jun 12;8(7):726-731. doi: 10.1021/acsmedchemlett.7b00127. eCollection 2017 Jul 13. ACS Med Chem Lett. 2017. PMID: 28740606 Free PMC article.

8

Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.

Gomez-Soler M, Petersen Gehring M, Lechtenberg BC, Zapata-Mercado E, Hristova K, Pasquale EB. Gomez-Soler M, et al. Among authors: lechtenberg bc. J Biol Chem. 2019 May 31;294(22):8791-8805. doi: 10.1074/jbc.RA119.008213. Epub 2019 Apr 23. J Biol Chem. 2019. PMID: 31015204 Free PMC article.

9

A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain.

Light TP, Gomez-Soler M, Wang Z, Karl K, Zapata-Mercado E, Gehring MP, Lechtenberg BC, Pogorelov TV, Hristova K, Pasquale EB. Light TP, et al. Among authors: lechtenberg bc. J Biol Chem. 2021 Jul;297(1):100876. doi: 10.1016/j.jbc.2021.100876. Epub 2021 Jun 15. J Biol Chem. 2021. PMID: 34139238 Free PMC article.

10

Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker.

Lechtenberg BC, Gehring MP, Light TP, Horne CR, Matsumoto MW, Hristova K, Pasquale EB. Lechtenberg BC, et al. Nat Commun. 2021 Dec 2;12(1):7047. doi: 10.1038/s41467-021-27343-z. Nat Commun. 2021. PMID: 34857764 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page